检索历史清除

首页> Science Immunology> Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity

Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity

导出原文传递

翻译打印收藏纠错

作者： Liu, Zhida ^[1] ; Han, Chuanhui ^[1] ; Dong, Chunbo ^[1] ; Shen, Aijun ^[1] ; Hsu, Eric ^[1] ; Ren, Zhenhua ^[1] ; Lu, Changzheng ^[1] ; Liu, Longchao ^[1] ; Zhang, Anli ^[1] ; Timmerman, Casey ^[1] ; Pu, Yang ^[1] ; Wang, Yang ^[1] ; Chen, Mingyi ^[1] ; Qiao, Jian ^[1] ; Fu, Yang-Xin ^[1]

作者单位： UT Southwestern Med Ctr, Dept Pathol, Dallas, TX 75235 USA ^[1]

发布时间 2019-10-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交